News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
664,760 Results
Type
Article (31570)
Company Profile (173)
Press Release (633013)
Multimedia
Podcasts (51)
Webinars (10)
Section
Business (209854)
Career Advice (702)
Deals (31424)
Drug Delivery (75)
Drug Development (72575)
Employer Resources (53)
FDA (15317)
Job Trends (12840)
News (311347)
Policy (28925)
Tag
2025 Best Places to Work (1)
2026 Best Places to Work (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (5)
2027 Genetown Elite (3)
2027 Genetown Premier (1)
2027 Genetown Standard (4)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
40 Under 40 (1)
Academia (1993)
Accelerated approval (49)
ADA (40)
Adcomms (12)
Allergies (192)
Alliances (44189)
ALS (212)
Alzheimer's disease (1597)
Antibody-drug conjugate (ADC) (521)
Approvals (16217)
Artificial intelligence (656)
ASCO (272)
Autoimmune disease (375)
Automation (43)
Bankruptcy (320)
Belgium (18)
Best Places to Work (10167)
BIO (53)
Biologics (64)
BIOSECURE Act (6)
Biosimilars (191)
BioSpace Insights (82)
Biotechnology (104)
Bispecific (42)
Bladder cancer (219)
Brain cancer (70)
Breast cancer (805)
Cancer (6251)
Cardiovascular disease (456)
Career advice (618)
Career pathing (20)
CAR-T (300)
CDC (39)
CDMO (78)
Celiac Disease (7)
Cell-line development (1)
Cell therapy (794)
Cervical cancer (57)
Clinical research (66236)
Collaboration (2019)
Commercialization (44)
Company closure (2)
Compensation (1663)
Complete response letters (58)
COVID-19 (1887)
CRISPR (97)
CRO (3)
C-suite (1282)
Cystic fibrosis (134)
Data (9252)
Decentralized trials (3)
Denatured (28)
Depression (170)
Dermatology (164)
Diabetes (655)
Diagnostics (6142)
Digital health (62)
Diversity (8)
Diversity, equity & inclusion (17)
Drug discovery (268)
Drug pricing (159)
Drug shortages (25)
Duchenne muscular dystrophy (260)
Earnings (85011)
Editorial (43)
Employer branding (6)
Employer resources (54)
ESMO (421)
Events (111782)
Executive appointments (1079)
Eye disease (11)
FDA (19818)
Fibrodysplasia Ossificans Progressiva (13)
Fragile X (4)
Friedreich's ataxia (26)
Frontotemporal dementia (31)
Funding (1617)
Gene editing (190)
Generative AI (42)
Gene therapy (578)
GLP-1 (807)
Government (3586)
Grass and pollen (4)
Guidances (394)
Healthcare (16828)
Hematology (160)
HIV (88)
Huntington's disease (55)
Idiopathic pulmonary fibrosis (13)
IgA nephropathy (120)
Immunology and inflammation (184)
Immuno-oncology (106)
Indications (257)
Infectious disease (2205)
Inflammatory bowel disease (225)
Inflation Reduction Act (13)
Influenza (125)
Intellectual property (320)
Interviews (80)
IPO (14669)
IRA (41)
Job creations (3053)
Job search strategy (568)
JPM (19)
Kidney cancer (25)
Kidney disease (138)
Labor market (58)
Layoffs (253)
Leadership (12)
Legal (7133)
Licensing (71)
Liver cancer (91)
Longevity (42)
Lung cancer (924)
Lung diease (16)
Lymphoma (464)
Machine learning (48)
Management (19)
Manufacturing (921)
Marketing (30)
MASH (183)
Medical affairs (5)
Medical device (14530)
Medtech (14835)
Mergers & acquisitions (18143)
Metabolic disorders (1430)
mRNA (157)
Multiple sclerosis (204)
Multispecific (3)
NASH (12)
Netherlands (20)
Neurodegenerative disease (394)
Neuropsychiatric disorders (82)
Neuroscience (3163)
Neurotech (2)
NextGen: Class of 2026 (5480)
Non-profit (3305)
Now hiring (51)
Obesity (559)
Opinion (135)
Ovarian cancer (253)
Pain (298)
Pancreatic cancer (351)
Parkinson's disease (356)
Partnered (29)
Patents (638)
Patient advocacy (5)
Patient recruitment (867)
Patient selection (81)
Peanut (62)
People (55504)
Peptides (24)
Pharmaceutical (40)
Pharmacy benefit managers (26)
Phase 1 (20517)
Phase 2 (29066)
Phase 3 (21514)
Pipeline (11842)
Policy (193)
Postmarket research (2389)
Preclinical (8246)
Press Release (46)
Prostate cancer (339)
Psychedelics (45)
Radioligand (2)
Radiopharmaceuticals (338)
Rare diseases (1021)
Real estate (4695)
Recruiting (21)
Regenerative medicine (22)
Regulatory (24083)
Reports (36)
Research institute (1966)
Resumes & cover letters (89)
Rett syndrome (54)
RNA editing (18)
RSV (72)
Schizophrenia (179)
Series A (273)
Series B (198)
Service/supplier (6)
Sickle cell disease (103)
Special edition (10)
Spinal muscular atrophy (151)
Sponsored (22)
Startups (3109)
Stem cells (3)
Stomach cancer (16)
Substance use disorders (20)
Supply chain (103)
Switzerland (7)
Tariffs (40)
Tax incentives (2)
The Weekly (23)
Vaccines (805)
Venture capital (53)
Weight loss (336)
Wet AMD (4)
Women's health (151)
Worklife (5)
Date
Today (59)
Last 7 days (707)
Last 30 days (2548)
Last 365 days (26507)
2026 (22079)
2025 (26048)
2024 (30758)
2023 (35198)
2022 (45657)
2021 (49467)
2020 (47607)
2019 (39027)
2018 (29427)
2017 (27589)
2016 (27067)
2015 (33406)
2014 (28523)
2013 (24205)
2012 (26508)
2011 (26904)
2010 (26034)
Location
Africa (521)
Alabama (95)
Alaska (4)
Arizona (411)
Arkansas (17)
Asia (34320)
Australia (5207)
California (14896)
Canada (4016)
China (1506)
Colorado (688)
Connecticut (629)
Delaware (442)
Europe (64491)
Florida (2292)
Georgia (490)
Hawaii (3)
Idaho (56)
Illinois (1261)
India (87)
Indiana (605)
Iowa (23)
Japan (656)
Kansas (132)
Kentucky (45)
Louisiana (54)
Maine (34)
Maryland (1768)
Massachusetts (10215)
Michigan (406)
Minnesota (821)
Mississippi (8)
Missouri (142)
Montana (28)
Nebraska (26)
Nevada (159)
New Hampshire (81)
New Jersey (3907)
New Mexico (20)
New York (3801)
North Carolina (1847)
North Dakota (8)
Northern California (7551)
Ohio (412)
Oklahoma (21)
Oregon (38)
Pennsylvania (2838)
Puerto Rico (30)
Rhode Island (56)
South America (763)
South Carolina (96)
South Dakota (1)
Southern California (6136)
Tennessee (247)
Texas (2504)
United States (51814)
Utah (460)
Vermont (1)
Virginia (329)
Washington D.C. (69)
Washington State (1196)
West Virginia (4)
Wisconsin (146)
Wyoming (3)
664,760 Results for "audax medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immuno-oncology
Astellas bets up to $1.34B for option to advance Audax immuno-oncology asset
Astellas Pharma could secure the exclusive global rights to Audax Biosciences’ DAX-044, an antibody-cytokine fusion therapy that activates the immune system in the vicinity of the tumor.
October 28, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Astellas and Audax Biosciences Enter Exclusive Option and License Agreement for DAX-044, a Novel Immune-Targeted IL-12 Antibody-Cytokine Fusion for Immuno-Oncology
October 27, 2026
·
5 min read
Press Releases
Belmont Medical Completes Acquisition of Arcos, Inc.
June 17, 2026
·
4 min read
Press Releases
Utah Medical Products, Inc. Reports Corrected Results of Tender Offer
October 29, 2026
·
1 min read
Press Releases
Medical Care Technologies Inc. (OTCID:MDCE) Highlights Accelerating Revenue Momentum, AI Commercialization and Expanding Subsidiaries
October 28, 2026
·
5 min read
Biotech Beach
Audax Private Equity Announces Growth Investment in Pyramid Laboratories, Inc.
Audax Private Equity (“Audax”), a leading alternative investment manager and capital partner, announced today that it has made a growth investment in Pyramid Laboratories, Inc. (“Pyramid” or the “Company”) to support the continued growth of the Company’s clinical and commercial biologics and advanced therapeutics manufacturing and service operations.
April 18, 2023
·
4 min read
Deals
Audax Private Equity Announces Agreement to Sell CorEvitas to Thermo Fisher Scientific
Audax Private Equity (“Audax”), a leading alternative investment manager and capital partner for North American middle market companies, announced today it has entered into a definitive agreement to sell CorEvitas, LLC (“CorEvitas”), a leading provider of real-world evidence for regulatory approved medical treatments and therapies, to Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”).
July 6, 2023
·
4 min read
Press Releases
The Regulation Of New Medical Tech Is Becoming A Lifelong Process
The Regulation Of New Medical Tech Is Becoming A Lifelong Process
October 26, 2026
·
1 min read
Press Releases
Utah Medical Products, Inc. Extends Tender Offer - October 5, 2026
October 5, 2026
·
1 min read
Press Releases
Medical Care Technologies Inc. (OTCID:MDCE) to Report Strongest Quarter of the Past Year in Upcoming Results
October 18, 2026
·
2 min read
1 of 66,476
Next
